Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6

References

• Breunig IM, Shaya FT, Tevie J, Roffman D. Incident depression increases medical utilization in Medicaid patients with hypertension. Expert Rev Cardiovasc Ther. 2015;13(1):111–18. doi:10.1586/14779072.2014.969712.
   PubMed Web of Science ®Google Scholar
• Grover S, Nebhinani N, Chakrabarti S, Avasthi A. Prevalence of metabolic syndrome among patients with depressive disorder admitted to a psychiatric inpatient unit: A comparison with healthy controls. Asian J Psychiatr. 2017;27:139–44. doi:10.1016/j.ajp.2017.02.030.
   PubMed Web of Science ®Google Scholar
• Patten SB, Williams JV, Lavorato DH, Campbell NR, Eliasziw M, Campbell TS. Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med. 2009;71(3):273–79. doi:10.1097/PSY.0b013e3181988e5f.
   PubMed Web of Science ®Google Scholar
• Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens. 2012;30(5):842–51. doi:10.1097/HJH.0b013e32835080b7.
   PubMed Web of Science ®Google Scholar
• Friedman MJ, Bennet PL. Depression and hypertension. Psychosom Med. 1977;39(2):134–42.
   PubMed Web of Science ®Google Scholar
• Nabi H, Chastang JF, Lefevre T, Dugravot A, Melchior M, Marmot MG, Shipley MJ, Kivimäki M, Singh-Manoux A. Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study. Hypertension. 2011;57(4):710–16. doi:10.1161/HYPERTENSIONAHA.110.164061.
   PubMed Web of Science ®Google Scholar
• Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014;8:25. doi:10.1186/1752-4458-8-25.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Chen L, Chen P, Hu Y. Prevalence of depression in patients with hypertension: a systematic review and meta-analysis. Medicine. 2015;94(31):e1317. doi:10.1097/MD.0000000000000874.
   PubMed Web of Science ®Google Scholar
• Sandstrom YK, Ljunggren G, Wandell P, Wahlstrom L, Carlsson AC. Psychiatric comorbidities in patients with hypertension–a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. J Hypertens. 2016;34(3):414–20. discussion 420. doi:10.1097/HJH.0000000000000824.
   PubMed Web of Science ®Google Scholar
• Keller NR, Diedrich A, Appalsamy M, Tuntrakool, S, Lonce, S, Finney, C, Caron, MG and Robertson, D. Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation. 2004;110(10):1191–96. doi:10.1161/01.CIR.0000141804.90845.E6.
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension. 2004;43(2):169–75. doi:10.1161/01.HYP.0000103160.35395.9E.
   PubMed Web of Science ®Google Scholar
• Wehrwein EA, Novotny M, Swain GM, Parker LM, Esfahanian M, Spitsbergen JM, Habecker BA, Kreulen DL. Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension. Auton Neurosci. 2013;179(1–2):99–107. doi:10.1016/j.autneu.2013.08.070.
   PubMed Web of Science ®Google Scholar
• Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73–93. doi:10.1146/annurev.ne.16.030193.000445.
   PubMed Web of Science ®Google Scholar
• Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci. 2000;3(5):465–71. doi:10.1038/74839.
   PubMed Web of Science ®Google Scholar
• Mata S, Urbina M, Manzano E, Ortiz T, Lima L. Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression. J Neuroimmunol. 2005;170(1–2):134–40. doi:10.1016/j.jneuroim.2005.08.007.
   PubMed Web of Science ®Google Scholar
• Kenney MJ, Ganta CK. Autonomic nervous system and immune system interactions. Compr Physiol. 2014;4(3):1177–200. doi:10.1002/cphy.c130051.
   PubMed Web of Science ®Google Scholar
• Ganta CK, Blecha F, Ganta RR, Helwig BG, Parimi S, Lu N, Fels RJ, Musch TI, Kenney MJ. Hyperthermia-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Physiol Genomics. 2004;19(2):175–83. doi:10.1152/physiolgenomics.00109.2004.
   PubMed Web of Science ®Google Scholar
• Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C, Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56(2):297–303. doi:10.1161/HYPERTENSIONAHA.110.150409.
   PubMed Web of Science ®Google Scholar
• Huang J, Tufan T, Deng M, Wright G, Zhu M-Y. Corticotropin releasing factor up-regulates the expression and function of norepinephrine transporter in SK-N-BE (2) M17 cells. J Neurochem. 2015;135(1):38–49. doi:10.1111/jnc.13268.
   PubMed Web of Science ®Google Scholar
• More SS, Itsara M, Yang X, Geier EG, Tadano MK, Seo Y, Vanbrocklin HF, Weiss WA, Mueller S, Haas-Kogan DA, et al. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clin Cancer Res. 2011;17(8):2339–49. doi:10.1158/1078-0432.CCR-10-2949.
   PubMed Web of Science ®Google Scholar
• Ma L, Li Y. The effect of depression on sleep quality and the circadian rhythm of ambulatory blood pressure in older patients with hypertension. J Clin Neurosci. 2017;39:49–52. doi:10.1016/j.jocn.2017.02.039.
   PubMed Web of Science ®Google Scholar
• Mushtaq M, Najam N. Depression, anxiety, stress and demographic determinants of hypertension disease. Pak J Med Sci. 2014;30(6):1293–98. doi:10.12669/pjms.306.5433.
   PubMed Web of Science ®Google Scholar
• Brendgen M, Ouellet-Morin I, Lupien S, Vitaro F, Dionne G, Boivin M. Does cortisol moderate the environmental association between peer victimization and depression symptoms? A genetically informed twin study. Psychoneuroendocrinology. 2017;84:42–50. doi:10.1016/j.psyneuen.2017.06.014.
   PubMed Web of Science ®Google Scholar
• Burrello J, Monticone S, Buffolo F, Tetti M, Veglio F, Williams T, Mulatero P. Is there a role for genomics in the management of hypertension? Int J Mol Sci. 2017;18:6. doi:10.3390/ijms18061131.
   Web of Science ®Google Scholar
• Scherrer JF, Xian H, Bucholz KK, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med. 2003;65(4):548–57.
   PubMed Web of Science ®Google Scholar
• Liang M, Cowley AW Jr., Mattson DL, Kotchen TA, Liu Y. Epigenomics of hypertension. Semin Nephrol. 2013;33(4):392–99. doi:10.1016/j.semnephrol.2013.05.011.
   PubMed Web of Science ®Google Scholar
• Menke A, Binder EB. Epigenetic alterations in depression and antidepressant treatment. Dialogues Clin Neurosci. 2014;16(3):395–404.
   PubMed Web of Science ®Google Scholar
• Nozik-Grayck E, Woods C, Stearman RS, Venkataraman S, Ferguson BS, Swain K, Bowler RP, Geraci MW, Ihida-Stansbury K, Stenmark KR, et al. Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2016;311(1):L124–L134. doi:10.1152/ajplung.00263.2015.
   PubMed Web of Science ®Google Scholar
• Chou AH, Chen YL, Hu SH, Chang YM, Wang HL. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation. Brain Res. 2014;1583:220–29. doi:10.1016/j.brainres.2014.08.019.
   PubMed Web of Science ®Google Scholar
• Marques FZ, Eikelis N, Bayles RG, Lambert EA, Straznicky NE, Hering D, Esler MD, Head GA, Barton DA, Schlaich MP, et al. A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. Mol Psychiatry. 2017;22(1):134–41. doi:10.1038/mp.2016.40.
   PubMed Web of Science ®Google Scholar
• Esler M, Alvarenga M, Pier C, Richards J, El-Osta A, Barton D, Haikerwal D, Kaye D, Schlaich M, Guo L, Jennings G The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol. 2006;20(4 Suppl):60–66.
   PubMedGoogle Scholar
• Bayles R, Baker EK, Jowett JB, Barton D, Esler M, El-Osta A, Lambert G. Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One. 2013;8(12):e83223. doi:10.1371/journal.pone.0083223.
   PubMed Web of Science ®Google Scholar
• Meng L, Chen D, Pei F, Hui R, Zheng Y, Chen J. DNA methylation in the norepinephrine transporter gene promoter region is not associated with depression and hypertension. Clin Exp Hypertens. 2017;39(6):539–45. doi:10.1080/10641963.2017.1288737.
   PubMed Web of Science ®Google Scholar
• Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, Bianchi R, Crisci M, D’Acierno L, Giordano R, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16(9):435. doi:10.1007/s11883-014-0435-z.
   PubMed Web of Science ®Google Scholar
• Welsh P, Grassia G, Botha S, Sattar N, Maffia P. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? Br J Pharmacol. 2017. doi:10.1111/bph.13818.
   PubMed Web of Science ®Google Scholar
• Schmid-Schonbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension. 1991;17(3):323–30.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Rossini C, Tincani A, Airò P, Scarsi M, Agabiti-Rosei C, Ruggeri G, Caimi L, Ricotta D, Agabiti-Rosei E, et al. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension. Blood Press. 2016;25(6):337–43. doi:10.1080/08037051.2016.1184495.
   PubMed Web of Science ®Google Scholar
• Gibas-Dorna M, Nowak D, Piatek J, Pupek-Musialik D, Krauss H, Kopczynski P. Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension. J Physiol Pharmacol. 2015;66(3):367–72.
   PubMed Web of Science ®Google Scholar
• Kaya C, Pabuccu R, Koca C, Oğuz AK, Erkan AF, Korkmaz A, Erbaş D. Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome. Fertil Steril. 2010;94(4):1437–43. doi:10.1016/j.fertnstert.2009.05.055.
   PubMed Web of Science ®Google Scholar
• Li NF, Yao XG, Zhu J, Yang J, Liu K-J, Wang Y-C, Wang X-L, Zu F-Y. Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens. 2010;32(1):54–60. doi:10.3109/10641960902993087.
   PubMed Web of Science ®Google Scholar
• Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815. doi:10.1037/a0035302.
   PubMed Web of Science ®Google Scholar
• Adebesin A, Adeoluwa OA, Eduviere AT, Umukoro S. Methyl jasmonate attenuated lipopolysaccharide-induced depressive-like behaviour in mice. J Psychiatr Res. 2017;94:29–35. doi:10.1016/j.jpsychires.2017.06.007.
   PubMed Web of Science ®Google Scholar
• Zhao X, Cao F, Liu Q, Li X, Xu G, Liu G, Zhang Y, Yang X, Yi S, Xu F, Fan K. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression. Behav Brain Res. 2017;364:494–502. doi: 10.1016/j.bbr.2017.05.064.
   Web of Science ®Google Scholar
• Ezquer ME, Valdez SR, Seltzer AM. Inflammatory responses of the substantia nigra after acute hypoxia in neonatal rats. Exp Neurol. 2006;197(2):391–98. doi:10.1016/j.expneurol.2005.10.015.
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15. doi:10.1016/j.bbi.2015.06.001.
   PubMed Web of Science ®Google Scholar